Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1990 Dec 1;172(6):1547–1557. doi: 10.1084/jem.172.6.1547

T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity

PMCID: PMC2188765  PMID: 2258695

Abstract

This study has examined the cellular and humoral responses underlying the rejection of rat renal allografts bearing an isolated RT1Aa class I MHC disparity. RT1Aa disparate kidneys were rejected promptly by high responder RT1u but not by low responder RT1c recipients (median survival time 10 d and greater than 100 d, respectively). The magnitude and phenotype of the cellular infiltrate were similar in rejecting and nonrejecting RT1Aa disparate kidneys. Paradoxically, graft infiltrating cells and spleen cells from RT1u recipients showed minimal ability to lyse donor strain lymphoblasts in vitro, whereas effector cells from RT1c recipients showed modest levels of cytotoxicity. Injection of RT1u rats with MRC OX8 mAb was highly effective at selectively depleting CD8+ cells from graft recipients but had no effect in prolonging the survival of RT1Aa disparate grafts despite the complete absence of CD8+ cells from the graft infiltrate, which included numerous CD4+ T cells and macrophages. RT1u, but not RT1c, recipients mounted a strong alloantibody response against RT1Aa disparate kidneys. Immune serum obtained from RT1u recipients that had rejected a RT1Aa disparate graft was able, when injected into cyclosporin-treated RT1u recipients, to restore their ability to reject a RT1Aa, but not a third-party RT1c, kidney. These results suggest that CD8+ cells in general and CD8+ cytotoxic effector cells in particular are unnecessary for the rapid rejection of RT1Aa class I disparate kidney grafts by high responder RT1u recipients. By implication, CD4+ T cells alone are sufficient to cause prompt rejection of such grafts and they may do so by providing T cell help for the generation of alloantibody.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong H. E., Bolton E. M., McMillan I., Spencer S. C., Bradley J. A. Prolonged survival of actively enhanced rat renal allografts despite accelerated cellular infiltration and rapid induction of both class I and class II MHC antigens. J Exp Med. 1987 Mar 1;165(3):891–907. doi: 10.1084/jem.165.3.891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barclay A. N. The localization of populations of lymphocytes defined by monoclonal antibodies in rat lymphoid tissues. Immunology. 1981 Apr;42(4):593–600. [PMC free article] [PubMed] [Google Scholar]
  3. Bolton E. M., Gracie J. A., Briggs J. D., Kampinga J., Bradley J. A. Cellular requirements for renal allograft rejection in the athymic nude rat. J Exp Med. 1989 Jun 1;169(6):1931–1946. doi: 10.1084/jem.169.6.1931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bradley J. A., Mason D. W., Morris P. J. Evidence that rat renal allografts are rejected by cytotoxic T cells and not by nonspecific effectors. Transplantation. 1985 Feb;39(2):169–175. doi: 10.1097/00007890-198502000-00012. [DOI] [PubMed] [Google Scholar]
  5. Butcher G. W., Corvalán J. R., Licence D. R., Howard J. C. Immune response genes controlling responsiveness to major transplantation antigens. Specific major histocompatibility complex-linked defect for antibody responses to class I alloantigens. J Exp Med. 1982 Jan 1;155(1):303–320. doi: 10.1084/jem.155.1.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Butcher G. W., Howard J. C. A recombinant in the major histocompatibility complex of the rat. Nature. 1977 Mar 24;266(5600):362–364. doi: 10.1038/266362a0. [DOI] [PubMed] [Google Scholar]
  7. Butcher G. W., Howard J. C. Genetic control of transplant rejection. Transplantation. 1982 Oct;34(4):161–166. [PubMed] [Google Scholar]
  8. Dijkstra C. D., Döpp E. A., Joling P., Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology. 1985 Mar;54(3):589–599. [PMC free article] [PubMed] [Google Scholar]
  9. Dvorak H. F., Mihm M. C., Jr, Dvorak A. M., Barnes B. A., Manseau E. J., Galli S. J. Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response. J Exp Med. 1979 Aug 1;150(2):322–337. doi: 10.1084/jem.150.2.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fabre J. W., Morris P. J. Studies on the specific suppression of renal allograft rejection in presensitised rats. Theoretical and clinical implications. Transplantation. 1975 Feb;19(2):121–133. doi: 10.1097/00007890-197502000-00004. [DOI] [PubMed] [Google Scholar]
  11. Flomenberg N., Naito K., Duffy E., Knowles R. W., Evans R. L., Dupont B. Allocytotoxic T cell clones: both Leu 2+3- and Leu 2-3+ T cells recognize class I histocompatibility antigens. Eur J Immunol. 1983 Nov;13(11):905–911. doi: 10.1002/eji.1830131109. [DOI] [PubMed] [Google Scholar]
  12. Forbes R. D., Guttmann R. D., Gomersall M., Hibberd J. A controlled serial ultrastructural tracer study of first-set cardiac allograft rejection in the rat. Evidence that the microvascular endothelium is the primary target of graft destruction. Am J Pathol. 1983 May;111(2):184–196. [PMC free article] [PubMed] [Google Scholar]
  13. Fukumoto T., McMaster W. R., Williams A. F. Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus. Eur J Immunol. 1982 Mar;12(3):237–243. doi: 10.1002/eji.1830120313. [DOI] [PubMed] [Google Scholar]
  14. Hall B. M., Dorsch S., Roser B. The cellular basis of allograft rejection in vivo. I. The cellular requirements for first-set rejection of heart grafts. J Exp Med. 1978 Oct 1;148(4):878–889. doi: 10.1084/jem.148.4.878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Holmdahl R., Olsson T., Moran T., Klareskog L. In vivo treatment of rats with monoclonal anti-T-cell antibodies. Immunohistochemical and functional analysis in normal rats and in experimental allergic neuritis. Scand J Immunol. 1985 Aug;22(2):157–169. doi: 10.1111/j.1365-3083.1985.tb01868.x. [DOI] [PubMed] [Google Scholar]
  16. Howard J. C., Butcher G. W. The mechanism of graft rejection and the concept of antigenic strength. Scand J Immunol. 1981 Dec;14(6):687–691. doi: 10.1111/j.1365-3083.1981.tb00611.x. [DOI] [PubMed] [Google Scholar]
  17. Hsiung L., Barclay A. N., Brandon M. R., Sim E., Porter R. R. Purification of human C3b inactivator by monoclonal-antibody affinity chromatography. Biochem J. 1982 Apr 1;203(1):293–298. doi: 10.1042/bj2030293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hunt S. V., Fowler M. H. A repopulation assay for B and T lymphocyte stem cells employing radiation chimaeras. Cell Tissue Kinet. 1981 Jul;14(4):445–464. doi: 10.1111/j.1365-2184.1981.tb00551.x. [DOI] [PubMed] [Google Scholar]
  19. Ichikawa T., Nakayama E., Uenaka A., Monden M., Mori T. Effector cells in allelic H-2 class I-incompatible skin graft rejection. J Exp Med. 1987 Oct 1;166(4):982–990. doi: 10.1084/jem.166.4.982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kamada N., Shinomiya T., Tamaki T., Ishiguro K. Immunosuppressive activity of serum from liver-grafted rats. Passive enhancement of fully allogeneic heart grafts and induction of systemic tolerance. Transplantation. 1986 Dec;42(6):581–587. doi: 10.1097/00007890-198612000-00002. [DOI] [PubMed] [Google Scholar]
  21. Like A. A., Biron C. A., Weringer E. J., Byman K., Sroczynski E., Guberski D. L. Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med. 1986 Oct 1;164(4):1145–1159. doi: 10.1084/jem.164.4.1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lowry R. P., Forbes R. D., Blackburn J. H., Marghesco D. M. Immune mechanisms in organ allograft rejection. V. Pivotal role of the cytotoxic-suppressor T cell subset in the rejection of heart grafts bearing isolated class I disparities in the inbred rat. Transplantation. 1985 Nov;40(5):545–550. [PubMed] [Google Scholar]
  23. Lowry R. P., Forbes R. D. The nonessential role of a humoral antibody response in acute rat cardiac allograft rejection. An ultrastructural tracer study in an adoptive transfer model. Transplantation. 1984 Feb;37(2):182–187. doi: 10.1097/00007890-198402000-00013. [DOI] [PubMed] [Google Scholar]
  24. Mintz B., Silvers W. K. Histocompatibility antigens on melanoblasts and hair follicle cells. Cell-localized homograft rejection in allophenic skin grafts. Transplantation. 1970 May;9(5):497–505. doi: 10.1097/00007890-197005000-00009. [DOI] [PubMed] [Google Scholar]
  25. Rosenberg A. S., Mizuochi T., Sharrow S. O., Singer A. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J Exp Med. 1987 May 1;165(5):1296–1315. doi: 10.1084/jem.165.5.1296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rosenberg A. S., Mizuochi T., Singer A. Analysis of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHC. 1986 Aug 28-Sep 3Nature. 322(6082):829–831. doi: 10.1038/322829a0. [DOI] [PubMed] [Google Scholar]
  27. Rosenberg A. S., Mizuochi T., Singer A. Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinants. J Exp Med. 1988 Jul 1;168(1):33–45. doi: 10.1084/jem.168.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rosenberg A. S., Singer A. Evidence that the effector mechanism of skin allograft rejection is antigen-specific. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7739–7742. doi: 10.1073/pnas.85.20.7739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sedgwick J. D. Long-term depletion of CD8+ T cells in vivo in the rat: no observed role for CD8+ (cytotoxic/suppressor) cells in the immunoregulation of experimental allergic encephalomyelitis. Eur J Immunol. 1988 Apr;18(4):495–502. doi: 10.1002/eji.1830180402. [DOI] [PubMed] [Google Scholar]
  30. Sedgwick J., Brostoff S., Mason D. Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system. J Exp Med. 1987 Apr 1;165(4):1058–1075. doi: 10.1084/jem.165.4.1058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Smith D. M., Stuart F. P., Wemhoff G. A., Quintáns J., Fitch F. W. Cellular pathways for rejection of class-I-MHC--disparate skin and tumor allografts. Transplantation. 1988 Jan;45(1):168–175. doi: 10.1097/00007890-198801000-00036. [DOI] [PubMed] [Google Scholar]
  32. Sprent J., Schaefer M., Lo D., Korngold R. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J Exp Med. 1986 Apr 1;163(4):998–1011. doi: 10.1084/jem.163.4.998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Stepkowski S. M., Ito T. Frequency of alloantigen-specific T cytotoxic cells in high- and low-responder recipients of class I MHC-disparate heart allografts. Transplantation. 1990 Jul;50(1):112–119. doi: 10.1097/00007890-199007000-00021. [DOI] [PubMed] [Google Scholar]
  34. Stewart R., Butcher G., Herbert J., Roser B. Graft rejection in a congenic panel of rats with defined immune response genes for MHC class I antigens. I. Rejection of and priming to the RT1Aa antigen. Transplantation. 1985 Oct;40(4):427–432. doi: 10.1097/00007890-198510000-00016. [DOI] [PubMed] [Google Scholar]
  35. Strassman G., Bach F. H. OKT4+ cytotoxic T cells can lyse targets via class I molecules and can be blocked by monoclonal antibody against T4 molecules. J Immunol. 1984 Oct;133(4):1705–1709. [PubMed] [Google Scholar]
  36. Sunderland C. A., McMaster W. R., Williams A. F. Purification with monoclonal antibody of a predominant leukocyte-common antigen and glycoprotein from rat thymocytes. Eur J Immunol. 1979 Feb;9(2):155–159. doi: 10.1002/eji.1830090212. [DOI] [PubMed] [Google Scholar]
  37. Swain S. L. T cell subsets and the recognition of MHC class. Immunol Rev. 1983;74:129–142. doi: 10.1111/j.1600-065x.1983.tb01087.x. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES